Novonesis A/s Class B · OMXCOP:NSIS_B
Novonesis A/s Class B — Novozymes — Q1 2015 Earnings Presentation
7 slides from Novonesis A/s Class B's earnings presentation, Apr 23, 2015
Slide 1: Conference Call Q1 2015
CONFERENCE CALL Q1 2015 April 23, 2015
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limited to, "bel
Slide 3: Q1 2015 Summary
Q1 2015 Summary Q1 2015 – overall in line with expectations Sales and organic growth • 8% organic sales growth, in line with expectations. Q1 2013 – Q1 2015 DKKm Sales up 18% in DKK compared with Q1 2014 12% 11% 4,000 • Strong growth in Agriculture & Feed – driven both 10% 3,579 3,000 by performance
Slide 4: Volatility in Household Care
Volatility in Household Care Household Care: growth fluctuates Current trading environment Quarterly organic growth rates, 2008-2015 1. Dynamic North American market with 30% trading-down and strong competition among detergent producers creates 20% challenging market and focus on cost reduction of f
Slide 5: Sales & Markets
Sales & Markets Q1 2015 sales: DKK +18%, organic +8% Sales by industry, DKKm Q1 2015 Q1 2014 • Household Care: Strong comparison in Q1 2014. Soft Household 1,127 Latin America sales. Dynamic consumer market +4%/-2% Care 1,080 tempers growth in North America • Food & Beverages: Good performance acr
Slide 6: Q1 2015 Financial Performance & Outlook
Q1 2015 Financial Performance & Outlook Satisfactory financial performance 2015 2015 Realized Outlook Outlook • Gross margin on par with Q1 2014 Key financials Q1 2015 Apr. 23 Jan. 20 • Disregarding the net one-time impact from The BioAg Sales growth, org. +8% 7-9% 7-9% Alliance, EBIT grew by ~20%,
Slide 7: Novozymes - Rethink Tomorrow
novozymes’ - Rethink Tomorrow